ClinicalTrials.govpublic full text
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
metastatic non-small cell lung cancer, non-squamous tumors, squamous tumors, pd-l1, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834966
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.